|
Test Catalog
|
|
TSC2 DNA Sequencing Test |
#522 |
|
| Type of Disorder: |
Epilepsy |
|
| Typical Presentation: |
Any combination of seizures, developmental delay, skin lesions, cortical tubers and hamartomas in various parts of the body |
|
| Disease(s) tested for: |
Tuberous Sclerosis |
|
| Test Details |
|
| Test Code: |
522 |
|
| Profiles that contain this test: |
Complete Tuberous Sclerosis Evaluation
|
|
| Informed Consent Required: |
Yes |
|
| Medicare ABN Required: |
Yes |
|
| Special Notes: |
Unless a family member has been confirmed by prior testing, it is recommended that this test be done as part of the Complete Tuberous Sclerosis Evaluation, #520 |
|
| Technical Information |
|
| Utility: |
Detects sequence variations in TSC2 gene |
|
| Methodology: |
Polymerase Chain Reaction (PCR) and DNA sequencing |
|
| Reference Value: |
No sequence variation detected |
|
| CPT Code(s): |
83891(1), 83898(42), 83904(42), 83909(1), 83912(1) |
|
| Patents: |
6,207,374, 6,232,452 |
|
| Shipping Considerations |
|
| Preferred Specimen Requirements |
| Type: |
Whole blood |
| Minimum Volume: |
20ml |
| Collection Tube: |
Lavender top (EDTA) |
|
| Storage Conditions: |
Room temperature |
|
| Shipping Conditions: |
Room temperature, avoid freezing. Ship same day, must arrive Monday - Friday. |
|
| Test Turnaround: |
6-8 weeks (Currently experiencing extended turnaround time of approx. 3-4 months) |
|
|
[back to top]
|
